Research Grid Raises $6.5 Million to Revolutionize Clinical Trials

Deal News | Nov 05, 2024 | PR Newswire Cision Research Grid Ltd

Research Grid, an AI startup focused on streamlining clinical trial processes, has successfully raised $6.5 million in a seed round led by Fuel Ventures. The company aims to eliminate the administrative burden associated with clinical trials by automating backend processes. This funding is crucial given that clinical trials are a major bottleneck in drug development, often plagued by delays due to outdated software and manual procedures. The new funds will be invested in research and development, expanding engineering teams, and enhancing marketing efforts to penetrate the U.S. and Asian markets. Research Grid's products, Inclusive and TrialEngine, offer comprehensive solutions that significantly enhance trial efficiency by automating data management, patient recruiting, and administrative operations. Founded by Dr. Amber Hill, a former medical researcher, the company leverages her insights into the intricacies of clinical trials to provide a robust and innovative solution. With a booming market for clinical trials projected to reach $95 billion in the next five years, investors show confidence in Research Grid’s potential to become a leader in this niche.

Sectors

  • Biotechnology
  • Artificial Intelligence
  • Healthcare Technology

Geography

  • United States – Research Grid is targeting to expand its operations in the U.S. market, which is influential in the clinical trials sector.
  • Asia – The company also aims to grow its presence in Asian markets, indicating its international expansion strategy.

Industry

  • Biotechnology – Research Grid operates in the biotechnology sector as it focuses on automating clinical trials, a critical component of drug development.
  • Artificial Intelligence – Research Grid uses AI technology to enhance operational efficiency in clinical trials, thereby classifying it within the AI sector.
  • Healthcare Technology – The company's mission to improve clinical trial efficacy through technology places it squarely in the healthcare technology industry.

Financials

  • $6.5 million – Amount raised in the seed funding round.
  • $400 million – Estimated annual cost savings per trial running to Phase 3 by eliminating inefficiencies in the back-office admin.
  • $95 billion – Projected market value of the clinical trial industry in the next five years.

Participants

NameRoleTypeDescription
Research GridTarget companyCompanyAn AI startup focused on automating administrative processes in clinical trials.
Fuel VenturesLead investorCompanyVenture capital firm leading the $6.5 million seed funding round.
Amber HillFounder and CEOPersonFounded Research Grid leveraging her experience as a former medical researcher with a Ph.D. in biomedical neuroscience.
Arve Capital, Ada Ventures, Morgan Stanley Inclusive Ventures Lab, Arāya Ventures, Ascension Ventures, Plug and Play Ventures, Atomico AngelsInvestorsCompaniesParticipating investors in the recent funding round.